Camille Debord

914 total citations
24 papers, 358 citations indexed

About

Camille Debord is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Camille Debord has authored 24 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Immunology and 7 papers in Genetics. Recurrent topics in Camille Debord's work include Acute Myeloid Leukemia Research (8 papers), Hematological disorders and diagnostics (5 papers) and Immune cells in cancer (4 papers). Camille Debord is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematological disorders and diagnostics (5 papers) and Immune cells in cancer (4 papers). Camille Debord collaborates with scholars based in France, Morocco and Germany. Camille Debord's co-authors include Marie C. Béné, G. Roussey, Isabelle Desguerre, Emma Allain‐Launay, M. Denis, Christine Barnérias, Yann Péréon, Sandra Mercier, Véronique Frémeaux‐Bacchi and Nicolas Chapuis and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Camille Debord

23 papers receiving 349 citations

Peers

Countries citing papers authored by Camille Debord

Since Specialization

Citations

This map shows the geographic impact of Camille Debord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Debord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Debord more than expected).

Fields of papers citing papers by Camille Debord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Debord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Debord. The network helps show where Camille Debord may publish in the future.

Co-authorship network of co-authors of Camille Debord

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Debord. A scholar is included among the top collaborators of Camille Debord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Debord. Camille Debord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders 2023 ·European Journal Of Haematology ·(unknown), Camille Debord, (unknown), Marion Eveillard, Marc Trossaërt, Catherine Ternisien, Marianne Sigaud, (unknown), Marie C. Béné, Marc Fouassier	0
2	Assessment of monocytic‐myeloid‐derived suppressive cells (M‐MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients 2023 ·SHILAP Revista de lepidopterología ·Pierre Péterlin, Marie C. Béné, (unknown), Thierry Guillaume, Amandine Le Bourgeois, Alice Garnier, Camille Debord, Marion Eveillard, Patrice Chevallier	2
3	Peripheral levels of monocytic myeloid‐derived suppressive cells before and after first induction predict relapse and survivals in AML patients 2022 ·Journal of Cellular and Molecular Medicine ·Pierre Péterlin, Camille Debord, Marion Eveillard, Alice Garnier, Amandine Le Bourgeois, Thierry Guillaume, (unknown), Marie C. Béné, Patrice Chevallier	8
4	Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy 2022 ·Blood Advances ·(unknown), (unknown), (unknown), Véronique Frémeaux‐Bacchi, Emma Allain‐Launay, Camille Debord, M. Denis, Yann Péréon, Christine Barnérias, Isabelle Desguerre, G. Roussey, Sandra Mercier	104
5	Higher Proportions of Monocytic-Myeloid-Derived Suppressive Cells (mMDSC) before Allotransplant Predict Relapse in Acute Leukemia Patients 2022 ·Blood ·Pierre Péterlin, Marie C. Béné, (unknown), Thierry Guillaume, Amandine Le Bourgeois, Alice Garnier, Camille Debord, Marion Eveillard, Patrice Chevallier	1
6	Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies 2020 ·British Journal of Haematology ·Élise Fournier, Camille Debord, Valérie Soenen, Nathalie Trillot, (unknown), (unknown), Louis Terriou, Coralie Derrieux, Wadih Abou Chahla, Camille Paris, Céline Berthon, Thomas Boyer, Anne Lambilliotte, Pierre Boisseau, (unknown), Marc Fouassier, Sophie Susen, Claude Preudhomme, Nicolas Duployez	8
7	Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft 2020 ·Scientific Reports ·(unknown), Thierry Guillaume, Pierre Péterlin, Alice Garnier, Amandine Le Bourgeois, Camille Debord, Beatrice Mahé, Viviane Dubruille, Soraya Wuillème, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Benoît Tessoulin, Yannick Le Bris, Marion Eveillard, (unknown), Philippe Moreau, Steven Le Gouill, Marie C. Béné, Patrice Chevallier	2
8	A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset 2018 ·Nature Communications ·Dorothée Selimoglu‐Buet, Julie Rivière, Hussein Ghamlouch, (unknown), Catherine Lacout, Margot Morabito, M’Boyba Diop, Guillaume Meurice, (unknown), Aurélie Chauveau, Camille Debord, Franck Debeurme, Raphaël Itzykson, Nicolas Chapuis, Christophe Willekens, Orianne Wagner‐Ballon, Olivier Bernard, Nathalie Droin, Éric Solary	28
9	A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN^TM analyzers in routine laboratory practice 2018 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), Élise Sourdeau, Marouane Boubaya, Lucile Baseggio, Sylvain Clauser, Édouard Cornet, Camille Debord, Jean‐Philippe Defour, Frédérique Dubois, Marion Eveillard, (unknown), (unknown), François Mullier, (unknown), Valérie Soenen, Pascal Morel, Francine Garnache‐Ottou, (unknown), Valérie Bardet, Éric Deconinck	12
10	A blueberry muffin rash at birth 2018 ·British Journal of Haematology ·Camille Debord, Audrey Grain, Olivier Theisen, (unknown), Fanny Rialland, Marion Eveillard	2
11	A novel complete blood count‐based score to screen for myelodysplastic syndrome in cytopenic patients 2018 ·British Journal of Haematology ·(unknown), Pierre Péterlin, Marouane Boubaya, Katja Sockel, Patrice Chevallier, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Camille Debord, Catherine Godon, Yannick Le Bris, Olivier Theisen, Frank Kroschinsky, Philippe Moreau, Marie C. Béné, Uwe Platzbecker, Marion Eveillard	17
12	Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults 2017 ·Bone Marrow Transplantation ·Yannick Le Bris, Thierry Guillaume, Armelle Ménard, (unknown), Jérôme C. Martin, (unknown), (unknown), Pierre Péterlin, Camille Debord, Nelly Robillard, Marion Eveillard, Soraya Wuillème, J. Delaunay, Mohamad Mohty, Alice Garnier, Philippe Moreau, Massimiliano Del Bene, Patrice Chevallier	2
13	CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy 2016 ·Blood ·Marion Eveillard, (unknown), Nelly Robillard, Camille Debord, Soraya Wuillème, Richard Garand, Fanny Rialland, Caroline Thomas, Pierre Péterlin, Thierry Guillaume, Philippe Moreau, Patrice Chevallier, Marie C. Béné	4
14	Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 2015 ·Haematologica ·Valérie Bardet, Orianne Wagner‐Ballon, Julien Guy, (unknown), Camille Debord, Franck Trimoreau, Emmanuel Benayoun, Nicolas Chapuis, (unknown), Cédric Rossi, Stéphanie Mathis, Marie-Pierre Gourin, Andréa Toma, Marie C. Béné, Jean Feuillard, Estelle Guérin, (unknown)	25
15	Leukemic phase of a large B-cell lymphoma arising in KSHV-associated multicentric Castleman disease 2015 ·Blood ·Camille Debord, Marion Eveillard	1
16	Abstract 2633: Vitamin D3 analog inecalcitol synergizes with tyrosine kinase inhibitors (TKI) and selectively inhibit the growth of chronic myeloid leukemia (CML) progenitors: Development of a clinically applicable leukemic stem cell targeting strategy 2015 ·Cancer Research ·Ali G. Turhan, (unknown), (unknown), Camille Debord, Rémi Delansorne, Agnès Guerci‐Bresler, (unknown), Annelise Bennaceur‐Griscelli	2
17	Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes 2013 ·Leukemia ·(unknown), Nicolas Chapuis, Camille Debord, Alexandra Rouquette, I Radford-Weiss, Sophie Park, François Dreyfus, C. Lacombe, Marie C. Béné, Olivier Kosmider, Michaëla Fontenay, Valérie Bardet	58
18	TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study 2012 ·Pediatric Research ·(unknown), Agathe de Lauzanne, Charles‐Henry Cottart, Emmanuel Curis, Camille Debord, Valérie Guérin‐El Khourouj, Béatrice Pédron, Albert Faye, Ghislaine Sterkers	24
19	Interferon-gamma Release Assay Performance for Diagnosing Tuberculosis Disease in 0- to 5-year-old Children 2011 ·The Pediatric Infectious Disease Journal ·Camille Debord, Agathe de Lauzanne, (unknown), Valérie Guérin‐El Khourouj, Béatrice Pédron, J. Gaudelus, Albert Faye, Ghislaine Sterkers	29
20	Potential value of CA125 kinetic monitoring in the initial management of advanced epithelial ovarian cancer 2011 ·Annales de biologie clinique ·Stéphane Vignot, (unknown), Camille Debord, (unknown), Maguy Bernard	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact